Abstract
Patients are at the heart of the generic and biosimilar medicine industries’ mission. We are committed to supplying them with high-quality medicines, delivering better value and ensuring the sustainability of our European healthcare systems. We are, and will continue pursuing this universal aim of a healthier society through trustworthy partnerships including EU institutions, national regulators, patient groups, healhtcare professionals and other stakeholders to increase public health in Europe.
Get full access to this article
View all access options for this article.